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Precise annotation of genes or open reading frames is still
a difficult task that results in divergence even for data
generated from the same genomic sequence. This has an
impact in further proteomic studies, and also compro-
mises the characterization of clinical isolates with many
specific genetic variations that may not be represented in
the selected database. We recently developed software
called multistrain mass spectrometry prokaryotic data-
base builder (MSMSpdbb) that can merge protein data-
bases from several sources and be applied on any pro-
karyotic organism, in a proteomic-friendly approach. We
generated a database for theMycobacterium tuberculosis
complex (using three strains of Mycobacterium bovis and
five of M. tuberculosis), and analyzed data collected from
two laboratory strains and two clinical isolates of M. tu-
berculosis. We identified 2561 proteins, of which 24 were
present in M. tuberculosis H37Rv samples, but not anno-
tated in theM. tuberculosis H37Rv genome. We were also
able to identify 280 nonsynonymous single amino acid
polymorphisms and confirm 367 translational start sites.
As a proof of concept we applied the database to whole-
genome DNA sequencing data of one of the clinical iso-
lates, which allowed the validation of 116 predicted single
amino acid polymorphisms and the annotation of 131 N-
terminal start sites. Moreover we identified regions not
present in the original M. tuberculosis H37Rv sequence,
indicating strain divergence or errors in the reference
sequence. In conclusion, we demonstrated the potential
of using a merged database to better characterize labo-
ratory or clinical bacterial strains. Molecular & Cellular
Proteomics 10: 10.1074/mcp.M110.002527, 1–10, 2011.
The annotation of a genomic DNA sequence with a list of
the predicted translated protein repertoire represents the fun-
damental basis for identification of peptide mass spectra in
proteomics (1–3). Therefore, the protein identification capacity
of proteomic experiments is dependent on a correct interpre-
tation and definition of the genome being studied. High-
throughput genome sequencing technology has led to an
exponential increase in the capacity to generate complete
genomic data for diverse organisms (4). According to the
Genome Online Database (http://www.genomesonline.org/
gold_statistics.htm) (5, 6), there were 1020 completed bacte-
rial genomes available during preparation of this article. The
accelerated rate of genomic sequencing projects and the
translation of this information into protein data sets represent
a welcome boost for the establishment and development of
proteomic studies for several organisms. However, such a
vast amount of sequence data from diverse genomes has
made open reading frame predictions dependent on auto-
matic computational analysis. It has been pointed out that
several errors have been introduced during the first stages of
nucleotide sequencing and open reading frame predictions,
and this has a major impact on subsequent studies (for a
review, see (7)).
This point can be demonstrated by comparing and testing
different gene annotations obtained from the same genomic
sequence. For example, the M. tuberculosis H37Rv gene an-
notations from the Sanger Institute and the JCV Institute differ
in 15% of the annotated genes, whereas for genes identified
by both annotations, different start codons were designated
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for 50% of them (8). Another species, like Mycobacterium
leprae, represents an even more extreme example, with a
300% difference in number of annotated genes (9). Not sur-
prisingly, comparison of protein identifications using primary
or secondary annotations clearly illustrates the limitations en-
countered if only one of the annotations is taken into consid-
eration for analysis of experimental proteomic data. This
shows that even for well characterized genomes there is no
consensus on how to determine an exact gene number, and
consequently also the identity and structure of the genes.
Many efforts have been put into creation of more suitable,
proteomics-friendly databases. These databases contain
compilations of protein entries from different sources such as
SwissProt (10), a manually curated protein database. For ex-
ample, the International Protein Index (IPI)1 (11) has been
well accepted and used by the proteomic community. The IPI
approach retrieves individual entries from different sources, and
through clustering of sequences based on sequence similarities
and cross-references, redundant proteins are reported only
once and unique entry information is also added. Current IPI
versions provide highly reliable genome coverage with a low
redundancy level. However, IPI is only available for seven spe-
cies (human, mouse, rat, zebra fish, Arabidopsis, chicken, and
cow), and does not include variations based on single amino
acid polymorphisms (SAPs). Concatenated databases such as
NCBInr have good organism coverage and also contain gene
entries from uncompleted genomes. However, database size
and entry redundancy might limit data analysis.
SAPs and other types of sequence variations can be in-
cluded in proteomics-friendly databases by adding the por-
tion of the sequence containing the mutation(s) after the main
entry sequence, but separated by the letter “J” to serve as a
neutral symbol (12). This approach does not increase the
redundancy of entries and therefore does not compromise the
statistics of the analysis. By applying this “MS-friendly”
method to the IPI human database, these authors were able to
identify many SAPs and processed N-terminal peptides in a
breast cancer cell line (MCF7). This approach has an obvious
potential for the analysis of prokaryotic clinical strains because
the characterization of proteins with polymorphisms is subop-
timal if the variants are not represented in the publicly available
database of a particular pathogen. In many cases antibiotic
resistance is caused by single nucleotide polymorphisms
(SNP)s, and recent data also suggests that microbial virulence
can be related to SNPs (13). It is therefore crucial to provide
protein databases that can compensate for annotation errors
and cover genetic variations among closely related organisms
that provide readily identifiable unique observations. Although
the same can be achieved by merely concatenating databases
of interest, database size and data analysis will become an
issue as more genomic information is made available.
We have therefore developed a software for prokaryotic ge-
nomes termedMultistrainMass Spectrometry prokaryote data-
base builder (MSMSpdbb) to perform clustering of homologous
protein entries from different sources (14). This is similar to what
is achieved by the IPI format, but we also add information about
different translational start site (TSS) choices, SAPs and other
mutations in line with what was reported for eukaryotic orga-
nisms (12). We used the publicly available nonredundant M.
tuberculosis complex protein database, and analyzed mass
spectrometry data collected from different fractions of the M.
tuberculosis H37Rv and M. tuberculosis H37Ra laboratory
strains, plus samples from two clinical M. tuberculosis Beijing
isolates. Our data demonstrate the potential for MSMSpdbb-
generated databases to identify relevant SAPs, as well as iden-
tification of proteins annotated in only a subset of the genomes.
Furthermore, we have found a highly abundant protein from the
ESAT-6 family in theM. tuberculosis H37Rv ATCC 27294 strain
that is encoded in an area of the genome sequence not de-
scribed within the original M. tuberculosis H37Rv genomic se-
quence (a non-ATCC strain) (15).
EXPERIMENTAL PROCEDURES
Generation of a Database for the M. tuberculosis Complex—The
protein database in FASTA format was generated by in-house devel-
oped software named MSMSpdbb (14). Genomic sequences of M.
tuberculosis strains: CDC1551 (16), F11, H37Ra (17), H37Rv (15), and
KZN1435, as well as the M. bovis strains: AF2122/97 (18), BCG
Pasteur 1173P2, and BCG Tokyo 172 (19), together with annotated
protein information were used as a basis for the database. Only primary
annotations were used. i.e. gene annotations consequently per-
formed by independent groups were not considered. Only protein
products larger than 50 amino acids were considered during stop-to-
stop translation. Peptides describing different translational start site
choices or sequence differences across strains were only added if the
peptide sequence was longer than seven amino acids and shorter
than 35. Peptides containing amino acid ambiguities, i.e. containing
an X symbol because of not confirmed nucleotide determination in the
genome sequence, were not added. Whenever proteins from different
strains were clustered, the accession number and description to use
for the entry was retrieved in a prioritized manner where M. tubercu-
losis H37Rv had highest priority. Translated entries, which did not
cluster with any currently annotated genes, were discarded for the
annotated-only database option of MSMSpdbb. It is worth mention-
ing that MSMSpdbb protein entries will be larger. Consequently,
calculations for sequence coverage, molecular weight, and sequence
size as given in the final results are reported relative to the complete
protein entry.
Data Collection—All M. tuberculosis H37Rv data collected for this
work was derived from theM. tuberculosis H37Rv ATCC27294 strain.
High-resolution mass spectrometry data collected in the last 2 years
by our group was submitted for analysis with our in-house M. tuber-
culosis complex database. The samples included: M. tuberculosis
H37Rv culture filtrate fraction (8), M. tuberculosis H37Rv and M.
tuberculosis H37Ra membrane fractions (20), M. tuberculosis H37Rv
whole cell lysates (collected for this work), and whole cell lysates of
two different clinical Beijing isolates (21). In total, 142 MS acquisition
files were analyzed. See Supplementary file S1 for data acquisition
statistics (“Summary” sheet).
1 The abbreviations used are: IPI, International Protein Index; SAP,
single amino acid polymorphism; MSMSpdbb, multistrain mass spec-
trometry prokaryote database builder; TSS, translational start site;
SNP, single nucleotide polymorphism; CAN, acetonitrile.
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Gel Electrophoresis and In-Gel Digestion of Proteins—Fifty micro-
grams of protein sample was mixed with 15 l sodium-dodecyl-
sulfate (SDS) loading buffer containing 10 mM dithiotreitol, and boiled
for 5 min before separation using 4%–12% SDS-PAGE (NuPAGE kit,
Invitrogen, Carlsbad, CA). The protein bands were visualized with
Coomassie Brilliant Blue R-250 staining kit (Invitrogen). Protein lanes
were excised and washed twice with 50% acetonitrile (ACN) at room
temperature, until excess Coomassie Brilliant Blue and sodium-do-
decylsulfate were removed. The proteins were then reduced using 10
mM dithiotreitol in water at 58 °C for 1 h, and alkylated with 55 mM
iodacetamide in 100 mM NH4HCO3 pH 8.0 for 45 min at RT. The gel
pieces were washed twice 50 mM NH4HCO3, followed by gel dehy-
dration by 100% ACN. Gel pieces were rehydrated in 30 l 50 mM
NH4HCO3 containing 0.125 g of sequence-grade trypsin (Promega,
Madison, WI) overnight at 37 °C. Trypsin reaction was quenched
using 1% trifluoroacetic acid. The digested peptides were eluted by
incubating the gel pieces with 50 l 50% ACN for 20 min at room
temperature twice, plus a final wash with 100% ACN for 10 min.
Peptide mixtures were then desalted using STAGE-tips packed with
C18 resin (3 M, USA) (22).
Mass Spectrometry—All experiments were performed on a Dionex
Ultimate 3000 nano-LC system (Sunnyvale, CA) connected to a linear
quadrupole ion trap - Orbitrap (LTQ-Orbitrap) mass spectrometer
(ThermoElectron, Bremen, Germany) equipped with a nanoelectro-
spray ion source. For liquid chromatography separation we used an
Acclaim PepMap 100 column (C18, 3 m, 100 Å) (Dionex, Sunnyvale,
CA) capillary of 12 cm bed length. The flow rate was 0.3 l/min for the
nano column, and the solvent gradient was 7% B to 40% B in 87 min,
then 40%–80% B in 8 min. Solvent A was aqueous 2% ACN in 0.1%
formic acid, whereas solvent B was aqueous 90% ACN in 0.1%
formic acid.
The mass spectrometer was operated in the data-dependent mode
to automatically switch between Orbitrap-MS and LTQ-MS/MS ac-
quisition. Survey full scan MS spectra (from m/z 300 to 2000) were
acquired in the Orbitrap with resolution r  60,000 at m/z 400 (after
accumulation to a target of 1,000,000 charges in the LTQ). The
method used allowed sequential isolation of the most intense ions, up
to six, depending on signal intensity, for fragmentation on the linear
ion trap using collisionally induced dissociation at a target value of
10,000 charges.
For accurate mass measurements the lock mass option was en-
abled in MS mode and the polydimethylcyclosiloxane ions generated
in the electrospray process from ambient air were used for internal
recalibration during the analysis (23). Target ions already selected for
MS/MS were dynamically excluded for 60 s. General mass spectrom-
etry conditions were: electrospray voltage, 1.5 kV; no sheath and
auxiliary gas flow. Ion selection threshold was 500 counts for MS/MS,
and an activation Q-value of 0.25 and activation time of 30 ms were
also applied for MS/MS.
Protein Identification—All acquired data was processed and ana-
lyzed using MaxQuant (version 1.0.13.8), a software specifically de-
veloped for data acquired using high-resolution instrumentation (24).
MS/MS peak lists from individual 142 RAW files were generated using
Quant.exe tool from the MaxQuant package, using default extract-
_msn (Thermo) parameters. Protein identification was performed by
searching the data againstM. tuberculosis database generated by the
MSMSpdbb script. The database was also modified to contain re-
versed sequences of all entries as a control of false-positive identifi-
cations during analysis. Common contaminants, such as keratins,
BSA, trypsin, were also added to the database. We used MASCOT
Daemon for submission of multiple searches on a local Mascot server
v2.2 (Matrix Science). Our Mascot program was slightly modified to
recognize the letter codes “O” and “J” as an amino acid of mass 0.00.
In addition a special trypsin cleavage rule was created that recog-
nized the C- and N-terminal flanks of “O” and “J” as cleavage sites.
The search parameters were: Enzyme specificity: trypsin with no
proline restriction, modified to recognize O and J codes; Maximum
missed cleavages: three; carbamidomethyl (C) as fixed modification;
N-acetyl (Protein), oxidation (M), pyro-glu (Gln to pyro-Glu) and pyro-
glu (Glu to pyro-Glu) as variable modifications; peptide mass toler-
ance of 15 parts per million; MS/MS mass tolerance of 0.5 Da. The
M. tuberculosis complex database from MSMSpdbb (14) contained
9290 entries (4630 forward sequences, 4630 reverse sequences, 30
most common contaminants).
MaxQuant report identifications as “Protein groups,” where pro-
teins entries sharing all or part of the identified peptides are reported
as a single protein hit including all members in the family. If just part
of the peptides identified is shared by two or more entries, the group
is reported as one, and the “leading” name given is the one of the
protein with more unique observations. The presence of a unique
peptide sequence to a “protein group” is mandatory for the group to
be considered. Protein group identification and validation was per-
formed by the Identify.exe option from MaxQuant under the following
parameters: peptide and protein false discovery rate: 0.01 (1%),
minimal peptide length was seven, and to guarantee a high confi-
dence identification rate, the maximal allowed posterior error proba-
bility (PEP) was set to 0.15; minimal number of unique peptides per
protein: one. Overall, the average mass accuracy of the identified
peptides was 400 parts per billion.
Validation of De Novo DNA Sequencing Data—The DNA of the
clinical M. tuberculosis Beijing high virulent strain was isolated ac-
cording to the method of van Soolingen (25). DNA was sheared and
sequenced on a GS FLX system (Roche, 454 Life Sciences, Branford,
CT). 100,070,772 high-quality bases in sequencing reads of on aver-
age 250 bases were collected, with 22.7 fold coverage. The peptide
sequences, that were identified in the high virulent isolate as de-
scribed above, were subjected to an automated tBLASTN search
(BLAST 2.2.17, (26)) against the collection of short sequencing reads.
The peptides were considered to be confirmed if at least one BLAST
hit without a mismatch and coverage of 100% was detected in the
nucleotide read collection.
RESULTS
Structure and Redundancy of the Annotated M. tuberculo-
sis Complex Database—The clustered database of the anno-
tated proteins of the M. tuberculosis complex contained 4630
entries. From these, the MSMSpdbb software inserted 6636
new “J” peptides, representing SAPs and other sequence
variations. The ratio between number of entries and number of
sequence variations was 1:1.4, which indicates a high level of
sequence similarity among the members of the M. tuberculo-
sis complex. The number of “O” peptides representing pre-
dicted TSS choices was 10,158 (1:2.2), indicating that the
annotations gave discrepant TSS choices for most of the
entries. The database contained 60 sequence ambiguities
(represented as “X”). These were mainly derived from protein
sequences of the clinical M. tuberculosis isolate CDC1551.
Peptides containing such ambiguities were not used for re-
dundancy calculation or appended as “J” or “O” peptides to
the main sequence.
One of the issues that might be raised against database
merging and protein clustering is the fact that the merging
itself will generate additional redundancy at the peptide level,
even if the clustered proteins are not redundant per se. With
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this limitation in mind, we performed a redundancy check of
the tryptic peptides present in the M. tuberculosis H37Rv
database, as well as the merged and clustered M. tuberculo-
sis complex database generated by MSMSpdbb (14). Our
data shows that the M. tuberculosis H37Rv database has
62,173 tryptic peptides with seven amino acids or more. From
those, only 478 tryptic peptides were observed in two entries
or more. This means that, if a protein is identified based on a
single peptide hit, the chance of ambiguous gene identifica-
tion because of sequence redundancy is only 0.81%. In ad-
dition, the protein groups that share identical tryptic peptides
are very limited and can be easily distinguished. For example,
54 out of 60 peptides that are repeatedly observed in four
entries or more belong to more than 40 transposases present
in the M. tuberculosis H37Rv genome. Of the remaining six
peptides, four were observed in ESAT-6-like proteins.
When the clustered M. tuberculosis complex database was
analyzed, similar results were observed. From 81,574 tryptic
peptides with seven amino acids or more, 734 were observed
in more than one entry in two or more genomes. This indicates
a redundancy rate of 0.91%. More than one fifth of the redun-
dant peptides were derived from the highly homologous
transposases encoded in several locations throughout the
genomes. Because MSMSpdbb cluster and report only one
copy of the homolog genes, it is evident that peptide redun-
dancy will rather decrease than increase as compared with
one of the isolated databases. In addition, protein identifica-
tions will be based in unique peptides for 99.09% of the
entries in the database.
Proteomic Analysis—Using M. tuberculosis laboratory and
clinical strains, we performed high-resolution proteomic
screens with a LTQ-Orbitrap mass spectrometer. In total,
2561 different proteins were identified in this study. Sup-
plemental Data S1 contains the protein lists and Sup-
plemental Data S2 the peptide lists output of all fractions/
samples analyzed in this work. Each file contains information
about protein mass, number of peptides per identified protein,
peptide length, observed charge, observed mass over charge
ratio, measured peptide mass (Da), Mascot Score, PEP val-
ues, the presence of modifications (as N-terminal acetylation
or Met oxidation), and the error of the observed/theoretical
mass in parts per million. All this can be accessed in order to
verify data quality and representation. Supplemental Data S3
reports three lists: The list named “Full proteins” represent all
of the identified protein entries from all of the analyzed frac-
tions. The second list “SAPs” reports all SAPs identified in our
work, and the third list “TSS” shows all TSS choices. The
importance of this is discussed below.
Validation of TSS Choices and Nonpredicted Coding Se-
quences—The MSMSpdbb software was developed to build
stop-to-stop codon translations from genomic data. There-
fore, predicted TSS choices for previously annotated genes
had to be artificially inserted in the protein sequence of the
FASTA file. Fig. 1A and Fig. 2A illustrate examples of se-
quence entries used in theM. tuberculosis complex database.
Note that the predicted TSSs are inserted in the original
sequence after an “O” letter (in bold). Expected N-terminal
peptides are considered with a Met start, or with a start with
the amino acid at position2, because Met processing is also
possible.
In total, we validated 367 peptides preceded by “O,” which
confirms one of the TSS choices used for the corresponding
genes. Only one TSS choice was confirmed per gene. They
represent 8% of the genes present in the M. tuberculosis
complex database. Fig. 1 exemplifies one of these cases. In
Fig. 1A, the sequence of the stop-to-stop codon region con-
taining the gene Rv0390 [A8] (present in all of the eight ge-
nomes) is shown. This gene had two predicted TSS choices in
all the genomes used, one at V121 and another at M135. In
Fig. 1B, the MS/MS fragmentation pattern of peptide SYAG-
DITPLQAWEMLSDNPR is shown. In the original sequence,
this peptide is preceded by a valine and does not constitute a
tryptic peptide, which demonstrates why the peptide had to
be appended with the “O” code (see Methods).
Additionally, we were able to identify a few examples of
peptide products from genomic regions initially predicted to
be noncoding. Fig. 2A shows the entry sequence format of
protein Rv0175 [A8]. This protein had two possible pre-
dicted TSSs, one at V44 and one at V63. However, we
identified the peptide MEGDAGAGQLNPADANK which is
present from position M22 to K38. The presence of an
arginine in position 21 in the sequence does not allow us to
discriminate between M22, V9, or L14 as the possible TSS
choice, because the identified peptide is also a normally
occurring tryptic peptide.
Identification of M. tuberculosis H37Rv Primary Unannotated
Genes—The sequence clustering provided by MSMSpdbb also
allows the reporting of annotated genes that are specific to
one or some of the genomes, thereby reducing annotation
error discrepancies. For example, the annotated protein
MT2297 [A3] is annotated in the M. tuberculosis strains:
CDC1551, H37Ra (entry MRA_2257), and KZN1435 (entry
TBMG_04033) (Fig. 3A, black boxes schematically represent-
ing the gene presence). It is important to note that, whereas
the M. tuberculosis H37Rv and M. tuberculosis F11 annota-
tion efforts did not consider that region in the genome as
coding, both strains possess the region nonetheless. We
identified three peptides of this protein, with Mascot scores
from 54 to 81, in membrane fractions and whole cell lysate
fractions of M. tuberculosis H37Rv strains (Fig. 3B shows the
fragmentation pattern of one of those). This indicates that
the gene was not correctly annotated for that genome. In
total, we identified 24 genes inM. tuberculosis H37Rv or in the
clinical isolates, which were not correctly predicted by the M.
tuberculosis H37Rv annotation (Genolist) and would be dis-
carded if our database was not used.
Identification of SAPs in Clinical Isolates—We used both
laboratory and clinical strains to determine the presence of
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SAPs. In total, we identified 280 SAPs (Supplemental Data
S3), and mapped their occurrence in the 8 M tuberculosis
genomes (which were classified in a presence/absence matrix).
We analyzed two M. tuberculosis Beijing strains, one
high virulent (HV) and one low virulent, in order to charac-
terize divergence of clinical strains. From the 280 observed
SAPs among the four strains used in this work, 153 were
found in the clinical isolates. Interestingly, analysis of the
SAPs in the Beijing strains indicates that they diverge as
compared with the other clinical M. tuberculosis strains:
F11, CDC1551, and KZN (Supplemental Data S4). The Bei-
jing strains had 34 SAPs that were absent from at least one
of the M. tuberculosis clinical genomes (CDC1551, F11, and
KZN1435). From those, 17 SAPs were not present in M.
tuberculosis CDC1551. In addition, the Beijing strains also
had eight SAPs that were only observed in the M. bovis
strains. However, a proper comparison should be per-
formed by distance matrix analysis once we have the com-
pleted genomic sequences of the high virulent and low
virulent Beijing strains used in this work.
Validation of SAPs and Prediction of Translational Start
Sites: Application to DNA De Novo Sequencing—To demon-
strate the usefulness of our approach to de novo sequencing,
we compared the 249 peptides identified in the M. tubercu-
losis Beijing high virulent isolate to a collection of high-
throughput DNA sequencing reads of the same isolate. We
validated 247 peptides that were found by comparison to a
collection of DNA reads covering all six reading frames. The
comparison allowed the determination of 131 N-terminal start
sites. Additionally, 116 SAPs were confirmed. Only two out of
249 peptides (false discovery rate of 0.80%) were absent in
the translations of the six reading frames, which is in accord-
ance with the 1% false discovery rate reported in the pro-
teomic analysis. Both these peptides might represent possi-
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FIG. 1. TSS choice validation for pro-
tein Rv0390. A, The entry in FASTA for-
mat is shown. Underlined region delimit
the expected tryptic peptides of two pre-
dicted TSS choices, a valine and a me-
thionine (bold, underlined). These tryptic
peptides were artificially added in the
end of the entry after the letter code “O”
(bold). B, Fragmentation profile of pep-
tide SYAGDITPLQAWEMLSDNPR.
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ble unexpected SAPs, because of variation in bacterial
subpopulations. The SAP from the protein Rv2935 is a pos-
sible example of this, because both expected and unexpected
polymorphic variants were discovered in the low virulent and
high virulent isolates with good Mascot scores. For the variant
observed in protein Rv3646c, however, a closer analysis of
the identified peptide revealed that the Mascot score might
indicate it is a false-positive identification in our database.
This peptide is shown in red in Supplemental Data S3.
Peptide Evidence Demonstrating Strain Divergence—When
searching against the M. tuberculosis complex database, we
made two observations that provide further evidence to sup-
port that the original M. tuberculosis H37Rv used for the
genomic sequence has a divergent genetic background when
compared with the ATCC strain, or even to M. tuberculosis
H37Ra orM. tuberculosis CDC1551. First, we identified a SAP
in the protein Rv2037c, which is present in all eight genomes,
except M. tuberculosis H37Rv. In this example, a cysteine
present in M. tuberculosis H37Rv is substituted to tyrosine in
the peptide FLANWNYADYLADCGGPFTPSL.
In addition, multiple peptides were observed, matching the
protein entry MT2420 [A2], an ESAT-6-like protein that is only
described in the M. tuberculosis CDC1551 and M. tuberculo-
sis H37Ra genomes (Fig. 4A). Fig. 4A also illustrate M. tuber-
culosis H37Rv representation of the same region, based on
the original genome sequence. In the original M. tuberculosis
H37Rv, the DNA region containing MT2420 and two other
genes (MT2421 and MT2422), is not supposed to exist, illus-
trating a possible deletion of that region in M. tuberculosis
H37Rv. However, Fig. 4B shows the MS/MS profile of one of
these peptides of m/z of 789.42, identified as AQAAALEAE-
HQAIVR with a Mascot score of 118 and 0.9 ppm mass accu-
racy. The four peptides identified for MT2420 in our work are
unique for this entry, and are not present in any other entry of
our M. tuberculosis complex database. This identification sug-
gests the existence of the DNA region containing the MT2420
“deletion” in the ATCC strain of M. tuberculosis H37Rv.
>MTC:Rv0175 [A8] Probable conserved MCE associated protein
TGGAGWCQVRRRKLEHNRRRRMEGDAGAGQLNPADANKSSSTEVKAADSAESDAGADQTG
PQVKAADSAESDAGELGEDACPEQALVERRPSRLRRGWLVGIAATLLALAGGLGAAGYFA
LRSHQESQSIAREDLAAIEAAKDCVAATQAPDAGAMSASMQKIIECGTGDFGAQASLYTS
MLVEAYQAASVHVQVTDMRAAVERNNNDGSVDVLVALRVKVSNTDSDAHEVGYRLRVRMA
LDEGRYKIAKLDQVTKOMKAADSAESDAGADQTGPQVKOKAADSAESDAGADQTGPQVKO
MKAADSAESDAGELGEDACPEQALVEROKAADSAESDAGELGEDACPEQALVERJSSSTE
VKAADSAESDAGELGEDACPEQALVER
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FIG. 2. Identification of regions pre-
dicted as noncoding. A, The entry in
FASTA format is shown, with the pre-
dicted N-terminal tryptic peptide under-
lined. The sequence in bold is present in
a region initially predicted as noncoding
in all eight genomes used in this work.
B, The fragmentation pattern of se-
quence MEGDAGAGQLNPADANK is
shown, indicating that this region is
indeed coding. This amino acid se-
quence is not present in any other gene
of the database.
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DISCUSSION
The current overwhelming number of complete and shot-
gun genomic sequences available in Genbank has boosted
genetic and genomic studies (for a review, see (27)). It has
also facilitated the visualization of genetic divergence among
closely related organisms, exemplified by the characterization
of horizontal gene transfers and SNPs, for example. However,
limitations with gene annotations from individual sources can
generate discrepancies, and such discrepancies will interfere
with the generation of an accurate protein database to be
used by proteomic approaches. As previously demonstrated
(8), the generation of databases with one in-silico approach
or without a good integration among other annotations can
result in less efficient characterization of an organism’s
proteome.
To avoid such discrepancies, we recently developed a soft-
ware to select genomic information and annotations from
different sources, merge them and generate a protein FASTA
database report with nonredundant information. We created a
database including the publicly available M. bovis and M.
tuberculosis genomic data. Initial analysis of M. tuberculosis
H37Rv whole cell lysates showed that proteomic data ana-
lyzed using the database generated by our script could iden-
tify unannotated genes of M. tuberculosis H37Rv as well as
peptides with SAPs (14). Herein, we expanded the evaluation
to a deep analysis of laboratory and clinical strains. In total we
identified 2561 proteins, comprising 63% of the genes pre-
dicted by Genolist, which contains the updated version of
the annotation initially presented by the M. tuberculosis ge-
nome sequencing project (15). Within these identifications, we
were able to determine genetic features such as the most
accurate TSS prediction for a gene, gene annotation discrep-
ancies, etc. This could be performed in a single analysis using
one database. The identification of SAPs in a clinical strain of
M. tuberculosis allowed the confirmation of SAPs predicted
by high-throughput sequencing. The determination of start
sites demonstrates the usefulness of the database for anno-
tation and validation of de novo sequencing projects.
Validation and interpretation of genomic information
through proteomic analysis can provide many advances to
diverse research fields. For example, the improvement of TSS
annotation and assignment can result in better identification
of promoter regions and other structural entities or regulatory
motifs (28, 29). This can consequently result in a better un-
derstanding of protein function and transcriptional regulation.
We were able to confirm not only 367 TSS choice divergences
(representing 9% of the primary M. tuberculosis H37Rv anno-
tation), but we also identified peptides from regions consid-
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FIG. 3. Identification of M. tuberculo-
sis H37Rv unannotated genes. A, Sche-
matic representation of the genomic re-
gion containing the gene MT2297 from
the M. tuberculosis CDC1551 strain.
Black boxes indicate gene annotation.
In M. tuberculosis H37Rv and M. tuber-
culosis F11 genomes, the gene is not
annotated but the genomic region is
nonetheless present. B, Fragmentation
pattern of peptide ADLYAAVDAMR
from MT2297, present in M. tuberculo-
sis H37Rv fractions.
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ered to be upstream of the predicted TSS choice. These
observations can be used to update database files to show
only the confirmed N-terminals. This information can also be
used to improve prediction algorithms. As supplemental ma-
terial, we are making public an improved version of our M.
tuberculosis complex database, where the protein sequence
entries containing the 367 confirmed TSS choices were mod-
ified accordingly so that the sequences of these proteins start
at the correct amino acid and predicted but inaccurate TSS
choices previously added as “O” peptides are deleted from
the entry (Supplemental Data S5).
One of the major limitations when characterizing the pro-
teome of clinical bacterial isolates is that it is hard to deter-
mine which of the available sequenced genome databases is
the most appropriate to use. This is the case because most, if
not all, protein search engines use the mass and the se-
quence information of the experimental data (30, 31). Even
slight mass variations resulting from a mutation of a lysine by
a glutamine (i.e. equal to 0.036 Da) can be reliably measured
by mass spectrometry instruments able to achieve precision
at the sub-ppm level. In such cases, using a database that
contains described SAPs or other variations are highly desir-
able, but proper attention to identifications containing SAP
mass shifts, which are isobaric to post-translational shifts,
(such as methionine oxidation) should always be given, to
avoid false-positives. Furthermore, it can consequently be
assumed that the usage of genome sequencing of clinical
strains is more appropriate in order to characterize not-se-
quenced clinical strains. However, our data suggests that a
randomly picked strain of epidemiological interest had a
higher SAP divergence with known clinical strains, and higher
similarity with the M. tuberculosis H37Rv and M. tuberculosis
H37Ra laboratory strains. Curiously, M. tuberculosis is largely
assumed to be a pathogen with a low rate of polymorphisms
(32, 33), but our data indicates that the genetic background of
clinical isolates of M. tuberculosis is variable. This might be
more evident when additional complete genomic information
is made available for M. tuberculosis strains (34, 35).
Finally, the most striking of our observations was the iden-
tification of the gene MT2420, which is not present in M.
tuberculosis H37Rv but is annotated in the M. tuberculosis
CDC1551 andM. tuberculosis H37Ra genomes. Recently, the
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FIG. 4. Missing region of the M. tuberculosis H37Rv genome. A, Alignment of selected gene sequences from M. tuberculosis CDC1551,
H37Ra, and H37Rv genomes, illustrating a deletion region in M. tuberculosis H37Rv that includes genes MT2420/MRA_2374 to MT2422/
MRA_2376. Interestingly,M. tuberculosis H37Rv andM. tuberculosis H37Ra share the same ancestor, but theM. tuberculosis H37Ra genome
sequence share more similarities with the M. tuberculosis CDC1551 genome than with the original M. tuberculosis H37Rv genome sequence. B,
Fragmentation pattern of peptide AQAAALEAEHQAIVR from MT2420, found in M. tuberculosis H37Rv (ATCC27294) whole cell lysates, indicating
that the deletion reported in the original M. tuberculosis H37Rv sequencing effort is incorrect. MS/MS information tables (MaxQuant output) are
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genomic sequence of M. tuberculosis H37Ra was released,
as well as its comparison with the M. tuberculosis H37Rv and
M. tuberculosis CDC1551 genomic sequences (17). Surpris-
ingly the H37Ra genome, which is derived from the same
ancestral strain as M. tuberculosis H37Rv, showed a much
higher sequence similarity with the M. tuberculosis CDC1551
clinical strain. This includes many SNPs and even insertions
and deletions that were commonly observed in M. tuberculo-
sis H37Ra and M. tuberculosis CDC1551, but absent in M.
tuberculosis H37Rv. When selected domains of the M. tuber-
culosis H37Rv (ATCC27294) genome were resequenced, it
became clear that the ATCC27294 sequence had the same
SNPs as observed in M. tuberculosis H37Ra. These observa-
tions have raised concern about the genetic background of
the strain used in the firstM. tuberculosis genome sequencing
project (15). Our identification of a protein product from a
region that is supposed not to exist in M. tuberculosis H37Rv
supports recent DNA sequence-based findings indicating that
this region of the M. tuberculosis H37Rv whole genome se-
quence is not representative of the M. tuberculosis H37Rv
ATCC reference strain (36). Our discovery of a SAP in
Rv2037c, which was supposed to be absent in M. tuberculo-
sis H37Rv, reinforces our conclusion that this inaccuracy is
true for multiple regions of the M. tuberculosis H37Rv original
sequence. This demonstrates that our database is able to
decrease divergence originating from genomic errors or strain
divergence, and not only errors originating from divergent
open reading frame annotation approaches.
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